MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis

作者: Tongtong Hao , Zhenghua Wang , Jinhui Yang , Yi Zhang , Yafeng Shang

DOI: 10.1016/J.BIOPHA.2019.109666

关键词:

摘要: Abstract Background Prostate cancer (PCa) is the second most common among men globally. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been reported to be implicated in tumorigenesis and progression of PCa. However, pathogenesis MALAT1 PCa not thoroughly elaborated. Methods RT-qPCR assay was conducted measure expression MALAT1, microRNA-140 (miR-140) Baculoviral IAP repeat containing 6 (BIRC6) mRNA. Protein BIRC6 detected by western blot assay. Cell proliferative ability assessed MTS Edu retention assays. migratory invasive abilities were evaluated wound healing Transwell invasion assay, respectively. apoptotic rate examined using a flow cytometry. The interaction between miR-140 or 3′UTR explored luciferase, immunoprecipitation (RIP) pull down Xenograft models established further explore role molecular mechanism MALAT vivo. Results highly expressed human tumor tissues cell lines. knockdown inhibited proliferation, migration induced apoptosis MiR-140 could directly bind with 3′UTR. Moreover, BIRC mRNA protein through upregulating cells. Additionally, xenograft growth regulating miR-140/BIRC6 axis Conclusion hindered vitro vivo, hinting potential value management

参考文章(27)
Girish C. Shukla, Sailen Barik, Jagjit Singh, MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Molecular and Cellular Pharmacology. ,vol. 3, pp. 83- 92 ,(2011) , 10.4255/MCPHARMACOL.11.13
V Mouraviev, B Lee, V Patel, D Albala, T E B Johansen, A Partin, A Ross, R J Perera, Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Prostate Cancer and Prostatic Diseases. ,vol. 19, pp. 14- 20 ,(2016) , 10.1038/PCAN.2015.48
John N Hutchinson, Alexander W Ensminger, Christine M Clemson, Christopher R Lynch, Jeanne B Lawrence, Andrew Chess, A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains BMC Genomics. ,vol. 8, pp. 39- 39 ,(2007) , 10.1186/1471-2164-8-39
Fubo Wang, Shancheng Ren, Rui Chen, Ji Lu, Xiaolei Shi, Yasheng Zhu, Wei Zhang, Taile Jing, Chao Zhang, Jian Shen, Chuanliang Xu, Huiqing Wang, Haifeng Wang, Yang Wang, Bin Liu, Yaoming Li, Ziyu Fang, Fei Guo, Meng Qiao, Chengyao Wu, Qiang Wei, Danfeng Xu, Dan Shen, Xin Lu, Xu Gao, Jianguo Hou, Yinghao Sun, Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer Oncotarget. ,vol. 5, pp. 11091- 11102 ,(2014) , 10.18632/ONCOTARGET.2691
Christopher G. Low, Iris S. U. Luk, Dong Lin, Ladan Fazli, Kuo Yang, Yong Xu, Martin Gleave, Peter W. Gout, Yuzhuo Wang, BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0055837
Xin Dong, Dong Lin, Chris Low, Emily A. Vucic, John C. English, John Yee, Nevin Murray, Wan L. Lam, Victor Ling, Stephen Lam, Peter W. Gout, Yuzhuo Wang, Elevated Expression of BIRC6 Protein in Non–Small-Cell Lung Cancers is Associated with Cancer Recurrence and Chemoresistance Journal of Thoracic Oncology. ,vol. 8, pp. 161- 170 ,(2013) , 10.1097/JTO.0B013E31827D5237
Bob Djavan, Elisabeth Eckersberger, Julia Finkelstein, Helen Sadri, Samir S. Taneja, Herbert Lepor, Prostate-specific Antigen Testing and Prostate Cancer Screening Primary Care. ,vol. 37, pp. 441- 459 ,(2010) , 10.1016/J.POP.2010.05.001
Shuang Zhao, Mo-Fang Liu, Mechanisms of microRNA-mediated gene regulation Science in China Series C: Life Sciences. ,vol. 52, pp. 1111- 1116 ,(2009) , 10.1007/S11427-009-0152-Y
Rituparno Sen, Suman Ghosal, Shaoli Das, Subrata Balti, Jayprokas Chakrabarti, Competing Endogenous RNA: The Key to Posttranscriptional Regulation The Scientific World Journal. ,vol. 2014, pp. 896206- 896206 ,(2014) , 10.1155/2014/896206